These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 37935785)

  • 21. Bacterial and fungal co-infections among ICU COVID-19 hospitalized patients in a Palestinian hospital: a retrospective cross-sectional study.
    Naseef HA; Mohammad U; Al-Shami N; Sahoury Y; Abukhalil AD; Dreidi M; Alsahouri I; Farraj M
    F1000Res; 2022; 11():30. PubMed ID: 35811795
    [No Abstract]   [Full Text] [Related]  

  • 22. Antimicrobial use in patients with confirmed COVID-19 infection in the Philippines: a cross-sectional study.
    Dominguez RJ; Domingo-Cereno NA; Josue-Dominguez RT
    Western Pac Surveill Response J; 2023; 14(2):1-8. PubMed ID: 37475781
    [TBL] [Abstract][Full Text] [Related]  

  • 23. State-of-the-art review of secondary pulmonary infections in patients with COVID-19 pneumonia.
    Chong WH; Saha BK; Ananthakrishnan Ramani ; Chopra A
    Infection; 2021 Aug; 49(4):591-605. PubMed ID: 33709380
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of respiratory bacterial infections on mortality in Japanese patients with COVID-19: a retrospective cohort study.
    Nakagawara K; Kamata H; Chubachi S; Namkoong H; Tanaka H; Lee H; Otake S; Fukushima T; Kusumoto T; Morita A; Azekawa S; Watase M; Asakura T; Masaki K; Ishii M; Endo A; Koike R; Ishikura H; Takata T; Matsushita Y; Harada N; Kokutou H; Yoshiyama T; Kataoka K; Mutoh Y; Miyawaki M; Ueda S; Ono H; Ono T; Shoko T; Muranaka H; Kawamura K; Mori N; Mochimaru T; Fukui M; Chihara Y; Nagasaki Y; Okamoto M; Amishima M; Odani T; Tani M; Nishi K; Shirai Y; Edahiro R; Ando A; Hashimoto N; Ogura S; Kitagawa Y; Kita T; Kagaya T; Kimura Y; Miyazawa N; Tsuchida T; Fujitani S; Murakami K; Sano H; Sato Y; Tanino Y; Otsuki R; Mashimo S; Kuramochi M; Hosoda Y; Hasegawa Y; Ueda T; Takaku Y; Ishiguro T; Fujiwara A; Kuwahara N; Kitamura H; Hagiwara E; Nakamori Y; Saito F; Kono Y; Abe S; Ishii T; Ohba T; Kusaka Y; Watanabe H; Masuda M; Watanabe H; Kimizuka Y; Kawana A; Kasamatsu Y; Hashimoto S; Okada Y; Takano T; Katayama K; Ai M; Kumanogoh A; Sato T; Tokunaga K; Imoto S; Kitagawa Y; Kimura A; Miyano S; Hasegawa N; Ogawa S; Kanai T; Fukunaga K;
    BMC Pulm Med; 2023 Apr; 23(1):146. PubMed ID: 37101265
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bacterial co-infection at hospital admission in patients with COVID-19.
    Moreno-García E; Puerta-Alcalde P; Letona L; Meira F; Dueñas G; Chumbita M; Garcia-Pouton N; Monzó P; Lopera C; Serra L; Cardozo C; Hernandez-Meneses M; Rico V; Bodro M; Morata L; Fernandez-Pittol M; Grafia I; Castro P; Mensa J; Martínez JA; Sanjuan G; Marcos MA; Soriano A; Garcia-Vidal C;
    Int J Infect Dis; 2022 May; 118():197-202. PubMed ID: 35257905
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bacterial and Fungal Coinfection in Individuals With Coronavirus: A Rapid Review To Support COVID-19 Antimicrobial Prescribing.
    Rawson TM; Moore LSP; Zhu N; Ranganathan N; Skolimowska K; Gilchrist M; Satta G; Cooke G; Holmes A
    Clin Infect Dis; 2020 Dec; 71(9):2459-2468. PubMed ID: 32358954
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characteristics of procalcitonin in hospitalized COVID-19 patients and clinical outcomes of antibiotic use stratified by procalcitonin levels.
    So W; Simon MS; Choi JJ; Wang TZ; Williams SC; Chua J; Kubin CJ
    Intern Emerg Med; 2022 Aug; 17(5):1405-1412. PubMed ID: 35277828
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recommendations for antibacterial therapy in adults with COVID-19 - an evidence based guideline.
    Sieswerda E; de Boer MGJ; Bonten MMJ; Boersma WG; Jonkers RE; Aleva RM; Kullberg BJ; Schouten JA; van de Garde EMW; Verheij TJ; van der Eerden MM; Prins JM; Wiersinga WJ
    Clin Microbiol Infect; 2021 Jan; 27(1):61-66. PubMed ID: 33010444
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Infections of the lower respiratory tract in general practice].
    Cazzola M
    Infection; 1987; 15 Suppl 3():S113-9. PubMed ID: 3497107
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incidence and risk factors for clinically confirmed secondary bacterial infections in patients hospitalized for coronavirus disease 2019 (COVID-19).
    Park HS; McCracken CM; Lininger N; Varley CD; Sikka MK; Evans C; Villamagna AH; Makadia JT; McGregor JC
    Infect Control Hosp Epidemiol; 2023 Oct; 44(10):1650-1656. PubMed ID: 37184033
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incidence of co-infections and superinfections in hospitalized patients with COVID-19: a retrospective cohort study.
    Garcia-Vidal C; Sanjuan G; Moreno-García E; Puerta-Alcalde P; Garcia-Pouton N; Chumbita M; Fernandez-Pittol M; Pitart C; Inciarte A; Bodro M; Morata L; Ambrosioni J; Grafia I; Meira F; Macaya I; Cardozo C; Casals C; Tellez A; Castro P; Marco F; García F; Mensa J; Martínez JA; Soriano A;
    Clin Microbiol Infect; 2021 Jan; 27(1):83-88. PubMed ID: 32745596
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bacterial infection in coronavirus disease 2019 patients: co-infection, super-infection and how it impacts on antimicrobial use.
    Nedel W; da Silveira F; da Silva CF; Lisboa T
    Curr Opin Crit Care; 2022 Oct; 28(5):463-469. PubMed ID: 36017559
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reducing broad-spectrum antibiotic use in intensive care unit between first and second waves of COVID-19 did not adversely affect mortality.
    Chan XHS; O'Connor CJ; Martyn E; Clegg AJ; Choy BJK; Soares AL; Shulman R; Stone NRH; De S; Bitmead J; Hail L; Brealey D; Arulkumaran N; Singer M; Wilson APR
    J Hosp Infect; 2022 Jun; 124():37-46. PubMed ID: 35339638
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictors of respiratory bacterial co-infection in hospitalized COVID-19 patients.
    Bolker A; Coe K; Smith J; Stevenson K; Wang SH; Reed E
    Diagn Microbiol Infect Dis; 2022 Jan; 102(1):115558. PubMed ID: 34731685
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections.
    Schuetz P; Müller B; Christ-Crain M; Stolz D; Tamm M; Bouadma L; Luyt CE; Wolff M; Chastre J; Tubach F; Kristoffersen KB; Burkhardt O; Welte T; Schroeder S; Nobre V; Wei L; Bhatnagar N; Bucher HC; Briel M
    Evid Based Child Health; 2013 Jul; 8(4):1297-371. PubMed ID: 23877944
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SARS-CoV-2 and Chlamydia pneumoniae co-infection: A review of the literature.
    Frutos MC; Origlia J; Gallo Vaulet ML; Venuta ME; García MG; Armitano R; Cipolla L; Madariaga MJ; Cuffini C; Cadario ME;
    Rev Argent Microbiol; 2022; 54(3):247-257. PubMed ID: 35931565
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections.
    Schuetz P; Müller B; Christ-Crain M; Stolz D; Tamm M; Bouadma L; Luyt CE; Wolff M; Chastre J; Tubach F; Kristoffersen KB; Burkhardt O; Welte T; Schroeder S; Nobre V; Wei L; Bhatnagar N; Bucher HC; Briel M
    Cochrane Database Syst Rev; 2012 Sep; 2012(9):CD007498. PubMed ID: 22972110
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative incidence of early and late bloodstream and respiratory tract co-infection in patients admitted to ICU with COVID-19 pneumonia versus Influenza A or B pneumonia versus no viral pneumonia: wales multicentre ICU cohort study.
    Pandey M; May A; Tan L; Hughes H; Jones JP; Harrison W; Bradburn S; Tyrrel S; Muthuswamy B; Berry N; Pugh R; Sutton D; Campbell A; Morgan M
    Crit Care; 2022 Jun; 26(1):158. PubMed ID: 35655224
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Comparative Study on Bacterial Co-Infections and Prevalence of Multidrug Resistant Organisms among Patients in COVID and Non-COVID Intensive Care Units.
    Sathyakamala R; Peace AR; Shanmugam P
    J Prev Med Hyg; 2022 Mar; 63(1):E19-E26. PubMed ID: 35647371
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Secondary bacterial infections of the respiratory tract in COVID-19 patients.
    Mumcuoğlu İ; Çağlar H; Erdem D; Aypak A; Gün P; Kurşun Ş; Çakır EY; Aydoğan S; Kırca F; Dinç B
    J Infect Dev Ctries; 2022 Jul; 16(7):1131-1137. PubMed ID: 35905017
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.